Shanghai Fudan-zhangjiang Bio-pharmaceutical Co., Ltd.

This early-stage study tests a new drug called FZ-AD005 in people with advanced solid tumors, especially small cell lung cancer and large cell neuroendocrine carcinoma. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. About 162 adults…

This study tests a new drug called FZ-AD004 for the first time in people with advanced solid tumors that have spread. The goal is to find a safe dose and see if it can shrink tumors. About 121 adults aged 18 to 75 will take part, and the study will monitor side effects and how we…

This study tests a light-activated drug called hemoporfin to treat port-wine birthmarks (red or purple skin marks). About 84 adults aged 18 to 75 will receive either the drug or a placebo, followed by different amounts of light. The goal is to find the safest and most effective l…